Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    ALBPS.PA Gross Margin

    As of 2025-07-13, the Gross Margin of Biophytis SA (ALBPS.PA) is 7775.2%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    ALBPS.PA Gross Margin - Historical Value
    DateValue
    2023-12-31 7775.2%
    2022-12-31 -
    2021-12-31 -
    2020-12-31 -
    2019-12-31 -
    2018-12-31 -
    2017-12-31 -
    2016-12-31 -
    2015-12-31 -
    2014-12-31 -
    ALBPS.PA Gross Margin - Peers Comparison
    TickerNameValue
    ABVX.PAAbivax SA-19700%
    ALQGC.PAQuantum Genomics SA-14205.1%
    ALSEN.PASensorion SA7775.2%
    BGBIO.OLBergenbio ASA100%
    BINV.STBioInvent International AB42.4%
    BVXP.LBioventix PLC93.2%
    CANTA.STCantargia AB7775.2%
    DMYD B.STDiamyd Medical AB-10161.5%
    ETX.LE-Therapeutics PLC100%
    FARN.LFaron Pharmaceuticals Oy95.2%
    HPHA.DEHeidelberg Pharma AG74%
    IVA.PAInventiva SA146.3%
    IVACC.STIntervacc AB-29.9%
    KDS.ASKiadis Pharma NV-
    MAB.WAMabion SA59.6%
    NANOV.OLNordic Nanovector ASA7775.2%
    ORPHA.COOrphazyme A/S7775.2%
    ORY.MCOryzon Genomics SA-4700%
    OSE.PAOSE Immunotherapeutics SA100%
    POXEL.PAPoxel SA0.1%
    SANION.STSaniona AB85%
    SCLP.LScancell Holdings PLC90.1%
    SIGHT.PAGensight Biologics SA188.4%
    SNG.LSynairgen PLC68.8%
    TILS.LTiziana Life Sciences PLC63.2%
    VVY.ASVivoryon Therapeutics NV85.4%
    XBRANE.STXbrane Biopharma AB90.8%
    XSPRAY.STXSpray Pharma AB (publ)2539.9%
    Tickers added to watchlist